Pharmataxigraphy
The term pharmataxigraphy (PTG for short) was established by XQS Service GmbH together with the chair for business informatics and electronic government at the University of Potsdam and was first published in 2013 in the journal pharmind published by Editio Cantor Verlag with the publication of the same name, “Pharmataxigraphie” .
Conception
The concept of pharmataxigraphy (taxi = travel, graphics = recording) emerged from the fight against counterfeit medicines . However, it goes far beyond the concept of Track & Trace . Classic track & trace refers to shipment tracking, whereby the current status of the goods (place, time) and the processing events that have taken place on the goods can be called up. Pharmataxigraphy, on the other hand, focuses on a holistic view of the supply chain from the producer to the patient, which is not limited to the pure logistical process of the logistics service provider.
Pharmataxigraphy is traceability from the producer to the patient, coupled with other pharma-specific functions with regard to product chain analysis and B2C information. According to WHO Tasks, the process does not have to be viewed through to the patient. Pharmataxigraphy takes the term wider: It is not about the traceability of the pure logistics processes, but about track & trace on / up to each value chain. Patients are the central element in the creation of pharmaceutical value and the value chain can only be viewed comprehensively if the patient is included. The Track & Trace technology is used not only for logistical interaction, but also for internal company tasks and for communication between non-logistical actors in the supply chain with one another (producer, doctor, patient, etc.).
For example, end consumers should be able to access individualized producer information independently of the logistics service provider and their goods movement information in order to convince themselves of the authenticity of the products. The additional information on consumer safety is strictly channeled and only made available to certain actors in the supply chain. This avoids distortions of competition and direct influence on consumers by producers.